Xpert® BCR-ABL Ultra p190

Skip navigation

Request Info

Tests Explore all tests

Systems Explore all systems

Solutions A Passion for Better Patient Care

Insights Explore All Insights

Support Get Customer Support

About Us Request Information

Respiratory

HAI & Other Infectious Diseases

Blood Virology, Women's Health, & Sexual Health

TB & Emerging Infectious Diseases

Oncology & Human Genetics

Cepheid GeneXpert Systems

GeneXpert® System Software

Cepheid Connectivity and Interface Capabilities

partner-communities

Global Access

Eligibility & Pricing

Testing Everywhere

Antibiotic Stewardship

Oncology Diagnostics

Customized Testing for Your Institution

Knowing MORE Matters

Insight Hub

Resources

Webinars

Self-Service Support

Safety Data Sheets

Upload Instrument Data

IVDR Update

Specimen Collection

Certificate of Analysis

Mission and History

Our Leadership

Our Leadership

Sustainability

Business Development Opportunities

Meet the Cepheid Bike

Distributors

News

Events

Innovate with Cepheid

Careers

Our Leadership

Request Info

Order Now

Sensitive and quantitative monitoring of BCR-ABL p190 and ABL mRNA in patients with chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL)

Insights

Multiplex, syndromic, testing, multiplex testing

5m Read

January 07, 2026

TECH AND DISEASE TRENDS

Multiplex with Meaning: Cepheid’s Smart Approach to Molecular Diagnostic Testing

5m Watch

October 09, 2025

TECH AND DISEASE TRENDS

{{getSidebarNestedSelection() || 'Main menu'}}

Location / Language

Connect To Better Outcomes

Insights

Multiplex with Meaning: Cepheid’s Smart Approach to Molecular Diagnostic Testing

Inside Cepheid: Learn About Cepheid System Innovation with Fellows, Ron Chang and Doug Dority